Donga Socio Holdings - Asset Resilience Ratio

Latest as of June 2025: 1.85%

Donga Socio Holdings (000640) has an Asset Resilience Ratio of 1.85% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 000640 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩37.95 Billion
≈ $25.72 Million USD Cash + Short-term Investments

Total Assets

₩2.05 Trillion
≈ $1.39 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Donga Socio Holdings's Asset Resilience Ratio has changed over time. See 000640 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Donga Socio Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Donga Socio Holdings worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩37.95 Billion 1.85%
Total Liquid Assets ₩37.95 Billion 1.85%

Asset Resilience Insights

  • Limited Liquidity: Donga Socio Holdings maintains only 1.85% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Donga Socio Holdings Industry Peers by Asset Resilience Ratio

Compare Donga Socio Holdings's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
SIMCERE PHARMAC. GRP LTD
F:S2P
Drug Manufacturers - Specialty & Generic 0.44%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%

Annual Asset Resilience Ratio for Donga Socio Holdings (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Donga Socio Holdings.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.49% ₩9.95 Billion
≈ $6.75 Million
₩2.03 Trillion
≈ $1.38 Billion
-1.59pp
2023-12-31 2.08% ₩40.64 Billion
≈ $27.54 Million
₩1.96 Trillion
≈ $1.33 Billion
+1.46pp
2022-12-31 0.61% ₩10.63 Billion
≈ $7.20 Million
₩1.73 Trillion
≈ $1.17 Billion
-2.86pp
2021-12-31 3.48% ₩58.84 Billion
≈ $39.87 Million
₩1.69 Trillion
≈ $1.15 Billion
-0.21pp
2020-12-31 3.68% ₩55.67 Billion
≈ $37.73 Million
₩1.51 Trillion
≈ $1.02 Billion
-0.35pp
2019-12-31 4.03% ₩54.81 Billion
≈ $37.14 Million
₩1.36 Trillion
≈ $920.69 Million
+3.56pp
2018-12-31 0.48% ₩5.93 Billion
≈ $4.02 Million
₩1.24 Trillion
≈ $841.64 Million
+0.40pp
2017-12-31 0.08% ₩1.11 Billion
≈ $749.55K
₩1.46 Trillion
≈ $989.05 Million
-0.10pp
2016-12-31 0.17% ₩2.43 Billion
≈ $1.65 Million
₩1.40 Trillion
≈ $950.26 Million
-0.13pp
2015-12-31 0.30% ₩3.70 Billion
≈ $2.51 Million
₩1.22 Trillion
≈ $829.16 Million
+0.09pp
2014-12-31 0.21% ₩2.25 Billion
≈ $1.52 Million
₩1.08 Trillion
≈ $732.63 Million
-0.52pp
2013-12-31 0.73% ₩7.20 Billion
≈ $4.88 Million
₩988.28 Billion
≈ $669.74 Million
+0.52pp
2012-12-31 0.21% ₩3.59 Billion
≈ $2.43 Million
₩1.72 Trillion
≈ $1.17 Billion
-2.77pp
2011-12-31 2.98% ₩44.45 Billion
≈ $30.12 Million
₩1.49 Trillion
≈ $1.01 Billion
+2.16pp
2010-12-31 0.82% ₩10.09 Billion
≈ $6.84 Million
₩1.23 Trillion
≈ $836.45 Million
+0.66pp
2009-12-31 0.16% ₩1.69 Billion
≈ $1.14 Million
₩1.06 Trillion
≈ $716.50 Million
-0.43pp
2008-12-31 0.59% ₩4.52 Billion
≈ $3.06 Million
₩769.94 Billion
≈ $521.78 Million
-0.37pp
2007-12-31 0.96% ₩6.83 Billion
≈ $4.63 Million
₩713.72 Billion
≈ $483.68 Million
+0.05pp
2006-12-31 0.91% ₩6.62 Billion
≈ $4.49 Million
₩731.74 Billion
≈ $495.89 Million
-0.35pp
2005-12-31 1.25% ₩9.08 Billion
≈ $6.15 Million
₩724.29 Billion
≈ $490.84 Million
+0.04pp
2004-12-31 1.21% ₩8.56 Billion
≈ $5.80 Million
₩706.01 Billion
≈ $478.45 Million
-1.10pp
2003-12-31 2.31% ₩15.98 Billion
≈ $10.83 Million
₩691.41 Billion
≈ $468.56 Million
+0.08pp
2002-12-31 2.23% ₩13.18 Billion
≈ $8.93 Million
₩590.72 Billion
≈ $400.32 Million
-2.21pp
2001-12-31 4.44% ₩26.35 Billion
≈ $17.86 Million
₩593.63 Billion
≈ $402.30 Million
+0.49pp
2000-12-31 3.95% ₩21.63 Billion
≈ $14.66 Million
₩547.36 Billion
≈ $370.94 Million
--
pp = percentage points

About Donga Socio Holdings

KO:000640 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$367.37 Million
₩542.10 Billion KRW
Market Cap Rank
#13952 Global
#441 in Korea
Share Price
₩84200.00
Change (1 day)
+0.12%
52-Week Range
₩80800.00 - ₩124000.00
All Time High
₩215705.22
About

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of S… Read more